Physician profile
Terryan Douglas
NPI 1912418658
$2,859.05
in general payments reported to CMS, 2019-2025
19 companies · $33.32 in 2025
The $33.32 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $205 · 2022: $1,728 · 2023: $689 · 2024: $204 · 2025: $33.32.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $927.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $926.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $409.08 | 2022-2023 | Mounjaro |
| Astrazeneca Pharmaceuticals LP | $396.78 | 2022-2023 | Farxiga |
| Abbvie INC. | $333.58 | 2021-2023 | |
| Novo Nordisk INC | $302.95 | 2022-2023 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $243.00 | 2022-2023 | Repatha, Otezla |
| Abbott Laboratories | $200.10 | 2021-2023 | Freestyle Libre 3 |
| Bayer Healthcare Pharmaceuticals INC. | $171.14 | 2022 | |
| Edwards Lifesciences Corporation | $164.94 | 2024 | Sapien 3 Ultra Resilia |
| Biohaven Pharmaceutical Holding Company LTD. | $141.65 | 2022 | |
| Impulse Dynamics (USA) INC. | $119.41 | 2021 | |
| Glaxosmithkline, LLC. | $110.64 | 2022-2023 | Trelegy Ellipta |
| Boston Scientific Corporation | $98.35 | 2022-2025 | Watchman Flx |
| Exact Sciences Corporation | $60.69 | 2023 | Cologuard Collection Kit |
| Pfizer INC. | $32.06 | 2023 | |
| Kowa Pharmaceuticals America, INC. | $17.50 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Idorsia Pharmaceuticals US INC | $16.70 | 2023 | Quviviq |
| Novartis Pharmaceuticals Corporation | $14.84 | 2022 | |
| Janssen Pharmaceuticals, INC | $13.79 | 2022 | |
| Jazz Pharmaceuticals INC. | $11.85 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Terryan Douglas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.